APELLIS PHARMACEUTICALS INC - NOTE 3.500% 9/1

Historical Holders from Q3 2020 to Q4 2024

CUSIP
03753UAB2
Type / Class
Debt / NOTE 3.500% 9/1
All holders as of December 31, 2024
Q4 2024
Principal, excl. options
93.8M
Holdings value
$109M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
9
Number of buys
4
Number of sells
-2
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of APELLIS PHARMACEUTICALS INC - NOTE 3.500% 9/1

Period Principal Value Change Price Investors
2024 Q4 $93.8M $109M -$12.1M $1.16 9
2024 Q3 $106M $117M -$336K $1.10 9
2024 Q2 $106M $135M +$14.5M $1.28 9
2024 Q1 $92.4M $151M +$20.9M $1.63 13
2023 Q4 $93.8M $174M +$8.51M $1.63 11
2023 Q3 $87.8M $126M -$48.9M $1.26 11
2023 Q2 $86.9M $220M -$13.9M $2.40 14
2023 Q1 $94.2M $175M +$774K $1.86 9
2022 Q4 $93.8M $144M -$5.75M $1.54 11
2022 Q3 $93.8M $179M -$79.4M $1.95 12
2022 Q2 $139M $206M -$92.8M $1.49 12
2022 Q1 $200M $315M +$5.81M $1.58 16
2021 Q4 $198M $299M +$5.67M $1.51 22
2021 Q3 $197M $242M -$336M $1.23 22
2021 Q2 $401M $746M +$577M $1.86 37
2021 Q1 $96.6M $136M -$99.9M $1.40 20
2020 Q4 $211M $222M -$60.4M $1.68 28
2020 Q3 $215M $209M +$209M $1.07 26